Search results for "Hepatitis C virus"
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018
Spotlight on hepatocellular cancer
One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2018/04/27/6.htm
27 Apr 2018
Prophylactic HCV treatment with direct-acting antivirals appears safe in noninfected kidney recipients
Researchers studied 10 HCV-negative recipients of 10 HCV-positive donor kidneys in an open-label, nonrandomized trial.
https://gastroenterology.acponline.org/archives/2018/03/23/3.htm
23 Mar 2018
HCV treatment was successful among patients who used injection drugs
The open-label, single-arm, industry-funded phase 4 trial included patients who had used injection drugs within six months and had chronic hepatitis C virus (HCV), recruited at 19 sites in seven countries.
https://gastroenterology.acponline.org/archives/2018/01/26/2.htm
26 Jan 2018
Spotlight on hepatitis B vaccination
The Advisory Committee on Immunization Practices released new recommendations, a CDC-funded study examined vaccination rates among patients who have HIV infection, and the FDA approved a new vaccine.
https://gastroenterology.acponline.org/archives/2018/01/26/5.htm
26 Jan 2018
ACG guidelines advise on diagnosis, treatment of alcoholic liver disease
Patients with heavy alcohol use should be counseled that they are at increased risk for alcoholic liver disease, among other recommendations from the American College of Gastroenterology.
https://gastroenterology.acponline.org/archives/2018/01/26/1.htm
26 Jan 2018
Project ECHO model appears cost-effective for HCV diagnosis, treatment
The incremental cost-effectiveness ratio with Project ECHO versus usual care was $10,351 per QALY, with 95.6% of iterations falling below a willingness-to-pay threshold of $50,000 per QALY and more than 99.9% falling below a willingness-to-pay threshold of $100,000 per QALY.
https://gastroenterology.acponline.org/archives/2017/11/28/3.htm
28 Nov 2017
ACP, CDC issue best practice advice on HBV
Clinicians should screen for hepatitis B virus (HBV) in patients at high risk, such as those born in countries where the HBV prevalence is 2% or higher, men who have sex with men, patients who require immunosuppressive therapy, or patients with end-stage renal disease.
https://gastroenterology.acponline.org/archives/2017/11/28/7.htm
28 Nov 2017
Spotlight on screening in primary care
Patient-specific reminders for clinicians performed best for increasing colorectal cancer screening in a French study, while an EHR alert appeared to successfully increase hepatitis C virus screening rates for baby boomers in a U.S. health care system.
https://gastroenterology.acponline.org/archives/2017/09/22/5.htm
22 Sep 2017
Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment
The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.
https://gastroenterology.acponline.org/archives/2017/08/25/3.htm
25 Aug 2017